# Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

> **NCT00661999** · PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 502 (actual)

## Conditions studied

- Anemia
- Leukemia
- Lymphoma
- Lymphoproliferative Disorder
- Multiple Myeloma and Plasma Cell Neoplasm
- Precancerous Condition
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** darbepoetin alfa
- **DIETARY_SUPPLEMENT:** ferrous sulfate
- **DRUG:** sodium ferric gluconate complex in sucrose
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00661999
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 502 (ACTUAL)
- **Last updated:** 2011-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00661999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00661999, "Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00661999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*